FDA clears Bovie Medical J-Plasma generator incorporating Cool-Coag™ technology for use in various surgical procedures.

 

Courtesy: Bovie Medical

Bovie Medical recently received FDA clearance for its novel J-Plasma generator and handpiece featuring the company’s “COOL-COAG” technology.

 In Gynecological surgeries, J-­Plasma increases a surgeon’s ability to target endometriosis and chronic pelvic pain which may result in less inflammation, accelerated healing (as compared to electrocautery) reduced adhesion formation and improved outcomes in patients with chronic pelvic pain and endometriosis.

This one of a kind device performs tissue dissection with minimal thermal spread with excellent control of its plasma stream and can switch to monopolar or helium spray coagulation mode with just a push of button.

The J-Plasma® makes use of helium ionization process to produce a stable, focused beam of ionized gas that provides surgeons with greater precision, minimal invasiveness and an absence of conductive currents through the patient during surgery.

The plasma stream generated by passing inert helium gas over a blade can perform all the three functions of cutting, coagulating and vaporizing the tissues at a much lower temperature than CO2 lasers, thereby limiting damage. The surgeon also benefits using a single device and absence of any smoke, odor or eschar.

extension of the blade 

                               
The handpiece distinctive design allows the retraction or extension of the surgical blade between different mode of operation. When the plasma stream is switched off, the blade can be used as scalpel for incision and when the stream is put on it can be used for coagulation or blunt dissection.

retraction of the blade 

Robert Gershon, CEO of Bovie Medical said “The development of Bovie’s Cool-Coag technology is a direct result of feedback from surgeons who have used our J-Plasma product for procedures that require greater coagulation capability, specifically in the areas of gynecologic oncology and surgical oncology. The unique flexibility of Cool-Coag enables the surgeon to use J-Plasma to perform the most delicate procedures, where precision and low risk of injury to surrounding tissue are paramount and also have the full power of monopolar coagulation to control, pinpoint and diffuse bleeding as needed.”

Dennis Chi, MD, head of ovarian cancer surgery at Memorial Sloan Kettering Cancer Center “This new Cool-Coag technology has the potential to increase usage of the J-Plasma device in many of our most complex cancer procedures. It combines J-Plasma’s ability to be used close to vital structures with minimal collateral damage and standard full monopolar coagulation capability, all in one hand-held instrument.”

Plasma is one of the four fundamental states of matter besides solid, liquid, and gas. When a gas is ionized by passing current through it, electrons are stripped from its atoms, turning it into plasma.

The plasma energy is generated as a precise stream that dissipates rapidly as it comes in contact with the tissue, but with controlled penetration and minimal thermal effect.

Use of plasma cutter is going to open many new treatment avenues in near future specially in field of oncology. 

This video will demonstrate the extremely low thermal spread and remarkable precision of both ease and safety with J plasma helium based surgical technology.